Lessons learned in creating biomedical nanoparticles for human use
Friday, August 17, 2012 - 08:02
in Physics & Chemistry
Over the past six years, the National Cancer Institutes (NCI) Nanotechnology Characterization Laboratory (NCL), a key component of the NCIs Alliance for Nanotechnology in Cancer, has characterized more than 250 different nanomaterials developed by over 75 research groups. This extensive experience has given NCL staff a unique perspective on how to design safe and biocompatible nanomaterials for human use. In a paper published in the journal Integrative Biology, the NCL team shared some of the lessons they have learned.